And Pharmacia's new injectable COX-2 inhibitor, called Dynastat, could supplement or even supersede morphine.

FORBES: Magazine Article

The medicine, sold outside the United States under the brand name Dynastat, also had other adverse affects.

FORBES: Pfizer And Merck Face The Jury

The drug, still undergoing clinical trials in the U.S., seems to have the same side effects as the other COX-2 inhibitors, but in tests against morphine, ketorolac (Toradol) and a placebo, Dynastat was superior to morphine and the placebo and comparable to ketorolac in potency and duration.

FORBES: Health